抄録／抄録１　　　　（１）Ｖ

第90回日本感染症学会学術講演会抄録（I）

Ł\”ƒ-2005

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

日本内科学会雑誌第98巻第4号

日本内科学会雑誌第97巻第7号

パーキンソン病治療ガイドライン2002

研修コーナー

l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

03実習2・松井.pptx

第86回日本感染症学会総会学術集会後抄録（I）

κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

日本内科学会雑誌第102巻第4号

JSP58-program

Ｐ１〜１４／稲　〃

本文／目次（裏白）

プログラム

2 7 ( ) µ

2016.

第121回関東連合産科婦人科学会総会・学術集会　プログラム・抄録

日本医科大学医学会雑誌第7巻第2号

放射線専門医認定試験（２００９・２０回）／ＨＯＨＳ‐０５（基礎二次）

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

日歯雑誌（Ｈ１９・５月号）済／Ｐ６‐１６　クリニカル　　柿木　５

プログラム

プリント

ｎｓｇ０４－２８／ｋｙ２０８６８４３５６１０００４３０７７

δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

NewsLetter-No2

日歯雑誌（Ｈ２２・７月号）ＨＰ用／ｐ０６‐１６　クリニカル①　田崎

内科１０１巻３号／ｎａｉ０３‐０１（試験問題抜粋）

10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1

4 16 1 10:0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!! 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 ! 2 10:0010 : 28 1F Annex 1 3 15:0015 : 28 1F Annex 1 4 10:3010 : 58 1F Annex 1 1 15:3015

ｔｎｂｐ５９－２１＿Ｗｅｂ：Ｐ２／ｋｙ１３２３７９５０９６１０００２９４４

_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf

陦ｨ邏・2

ｎｓｇ０２－１３／ｋｙ０４５０５９３０１６０００３３２１０

φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

概況

2 4 6 2 2 2 3 2 4 22 5 23 27 34 37 44 45 46 2 78.67 85.77 2.6. 7. 2 2, 65 85,464 93,8 65 85.5 93.2 8 56.2 77.9 2 8.87 88.8 3 () 65 3 6 2 2 2 2 2 22 3 2 2 2 2 2 2 2 2 28.58 28.74 29.9 8.8 8.84 2.63 65 28.3

original: 2011/11/5 revised: 2012/10/30, 2013/12/ : 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q

original: 2011/11/5 revised: 2012/10/30, 2013/12/2 1 1 1: 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q 2 2 1 2 1 c 2013 2 2: V i Q 1 I C1 V C1 V B2 I E V E V E Q 1 Q 1 Q 2 Q 2 Q

ｓｎｋｐ－１４－２／ｋｙ３４７０８４２２０２０００１９１７５

zsj2017 (Toyama) program.pdf

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

日歯雑誌（Ｈ２８・８月号）別刷り／ポスターセッション　とびら

α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α

GJG160842_O.QXD

N cos s s cos ψ e e e e 3 3 e e 3 e 3 e

3 3 5 5 5 3 3 7 5 33 5 33 9 5 8 > e > f U f U u u > u ue u e u ue u ue u e u e u u e u u e u N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 > A A > A E A f A A f A [ ] f A A e > > A e[ ] > f A E A < < f ; >

3/4/8:9 { } { } β β β α β α β β

α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3

内科９６巻３号★／ＮＡＩ３‐１（第２２回試験問題）

µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2

O x y z O ( O ) O (O ) 3 x y z O O x v t = t = 0 ( 1 ) O t = 0 c t r = ct P (x, y, z) r 2 = x 2 + y 2 + z 2 (t, x, y, z) (ct) 2 x 2 y 2 z 2 = 0

9 O y O ( O ) O (O ) 3 y O O v t = t = 0 ( ) O t = 0 t r = t P (, y, ) r = + y + (t,, y, ) (t) y = 0 () ( )O O t (t ) y = 0 () (t) y = (t ) y = 0 (3) O O v O O v O O O y y O O v P(, y,, t) t (, y,, t )

研修コーナー

l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,

NL10

Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

日本医科大学医学会雑誌第8巻第1号

Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1

日本分子第5巻2号_15特別講演・シンポジウム.indd

25 JSMI Report JSMI Report 26 41 JSMI Report JSMI Report 42 JSMI Report 54 55 JSMI Report JSMI Report 56 57 JSMI Report JSMI Report 58 59 JSMI Report JSMI Report 60 61 JSMI Report β JSMI Report 62 63 JSMI

CVMに基づくNi-Al合金の

CV N-A (-' by T.Koyama ennard-jones fcc α, β, γ, δ β α γ δ = or α, β. γ, δ α β γ ( αβγ w = = k k k ( αβγ w = ( αβγ ( αβγ w = w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( βγδ w = = k k k ( αγδ

I II III IV V

I II III IV V N/m 2 640 980 50 200 290 440 2m 50 4m 100 100 150 200 290 390 590 150 340 4m 6m 8m 100 170 250 µ = E FRVβ β N/mm 2 N/mm 2 1.1 F c t.1 3 1 1.1 1.1 2 2 2 2 F F b F s F c F t F b F s 3 3 3

NL09

Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

感染症学雑誌第77巻第8号

1 2 µ Streptococcus pneumoniae µ S. pneumoniae µ S. pneumoniae pbp β β pbp1a pbp2x pbp2b pbp mefe ermb pbp pbp1a pbp2x pbp2b pbp pbp pbp pbp 2x pbp1a pbp2x pbp 2b mefe ermb pbp β pbp2x β β β µ µ pbp3 µ

「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書

1 2004 12 2005 4 5 100 25 3 1 76 2 Demoskop 2 2004 11 24 30 7 2 10 1 2005 1 31 2 4 5 2 3-1-1 3-1-1 Micromediabanken 2005 1 507 1000 55.0 2 77 50 50 /CEO 36.3 37.4 18.1 3-2-1 43.0 34.4 / 17.6 3-2-2 78 79.4

202

202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 DS =+α log (Spread )+ β DSRate +γlend +δ DEx DS t Spread t 1 DSRate t Lend t DEx DS DEx Spread DS

NL11

information September, 2007 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11 September, 2007 3 2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

ax 2 + bx + c = n 8 (n ) a n x n + a n 1 x n a 1 x + a 0 = 0 ( a n, a n 1,, a 1, a 0 a n 0) n n ( ) ( ) ax 3 + bx 2 + cx + d = 0 4

20 20.0 ( ) 8 y = ax 2 + bx + c 443 ax 2 + bx + c = 0 20.1 20.1.1 n 8 (n ) a n x n + a n 1 x n 1 + + a 1 x + a 0 = 0 ( a n, a n 1,, a 1, a 0 a n 0) n n ( ) ( ) ax 3 + bx 2 + cx + d = 0 444 ( a, b, c, d

数学概論I

{a n } M >0 s.t. a n 5 M for n =1, 2,... lim n a n = α ε =1 N s.t. a n α < 1 for n > N. n > N a n 5 a n α + α < 1+ α. M := max{ a 1,..., a N, 1+ α } a n 5 M ( n) 1 α α 1+ α t a 1 a N+1 a N+2 a 2 1 a n

.\ /......

教育 研究 社会貢献活動報告 香 川 医 科 大 学 平成１ ３年度 香川医科大学自己点検評価委員会 γ α β β β α β β γ γ α β αβ µ Anopheles Bolbosoma Leishmania Pneumocystis carinii P. carinii Bolbosoma Leishmania Anopheles Plasmodium

4 4 θ X θ P θ 4. 0, 405 P 0 X 405 X P 4. () 60 () 45 () 40 (4) 765 (5) 40 B 60 0 P = 90, = ( ) = X

4 4. 4.. 5 5 0 A P P P X X X X +45 45 0 45 60 70 X 60 X 0 P P 4 4 θ X θ P θ 4. 0, 405 P 0 X 405 X P 4. () 60 () 45 () 40 (4) 765 (5) 40 B 60 0 P 0 0 + 60 = 90, 0 + 60 = 750 0 + 60 ( ) = 0 90 750 0 90 0

1 12 *1 *2 (1991) (1992) (2002) (1991) (1992) (2002) 13 (1991) (1992) (2002) *1 (2003) *2 (1997) 1

2005 1 1991 1996 5 i 1 12 *1 *2 (1991) (1992) (2002) (1991) (1992) (2002) 13 (1991) (1992) (2002) *1 (2003) *2 (1997) 1 2 13 *3 *4 200 1 14 2 250m :64.3km 457mm :76.4km 200 1 548mm 16 9 12 589 13 8 50m

EPSON LP-8900ユーザーズガイド

3 4 5 6 7 8 abc ade w p s 9 10 s s 11 p 12 p 13 14 p s 15 p s A B 16 w 17 C p 18 D E F 19 p w G H 20 A B 21 C s p D 22 E s p w 23 w w s 24 p w s 25 w 26 p p 27 w p s 28 w p 29 w p s 30 p s 31 A s B 32

untitled

( 9:: 3:6: (k 3 45 k F m tan 45 k 45 k F m tan S S F m tan( 6.8k tan k F m ( + k tan 373 S S + Σ Σ 3 + Σ os( sin( + Σ sin( os( + sin( os( p z ( γ z + K pzdz γ + K γ K + γ + 9 ( 9 (+ sin( sin { 9 ( } 4

F = 0 F α, β F = t 2 + at + b (t α)(t β) = t 2 (α + β)t + αβ G : α + β = a, αβ = b F = 0 F (t) = 0 t α, β G t F = 0 α, β G. α β a b α β α β a b (α β)

19 7 12 1 t F := t 2 + at + b D := a 2 4b F = 0 a, b 1.1 F = 0 α, β α β a, b /stlasadisc.tex, cusp.tex, toileta.eps, toiletb.eps, fromatob.tex 1 F = 0 F α, β F = t 2 + at + b (t α)(t β) = t 2 (α + β)t

y = x x R = 0. 9, R = σ $ = y x w = x y x x w = x y α ε = + β + x x x y α ε = + β + γ x + x x x x' = / x y' = y/ x y' =

y x = α + β + ε =,, ε V( ε) = E( ε ) = σ α $ $ β w ( 0) σ = w σ σ y α x ε = + β + w w w w ε / w ( w y x α β ) = α$ $ W = yw βwxw $β = W ( W) ( W)( W) w x x w x x y y = = x W y W x y x y xw = y W = w w

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

MJR-35 34 1 1 a MRICT b 2Beecham r-afs 3 4 20 4 mg/ 20 40 5 6 2 1 2 3 44 mg/ 5 6 7 8 4 Gn-RH 742 9 10 11 12 1 20 60 1 1MJR-351 mg/ 0.25 2 Lot. No. 2MJR-352 mg/ 1 1 Lot. No. 3MJR-354 mg/ 1 2 Lot. No. 2

Lecture 12. Properties of Expanders

Lecture 12. Properties of Expanders M2 Mitsuru Kusumoto Kyoto University 2013/10/29 Preliminalies G = (V, E) L G : A G : 0 = λ 1 λ 2 λ n : L G ψ 1,..., ψ n : L G µ 1 µ 2 µ n : A G ϕ 1,..., ϕ n : A G (Lecture

Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology

Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology evolute involute, evolvent involute : involvo evolvent : evolvo 6 4 6 4 4 6 4 6 H 3 γ : I R C γ(t) 0, t(t) := γ(t) γ(t),

‚åŁÎ“·„´Šš‡ðŠp‡¢‡½‹âfi`fiI…A…‰…S…−…Y…•‡ÌMarkovŸA“½fiI›ð’Í

Markov 2009 10 2 Markov 2009 10 2 1 / 25 1 (GA) 2 GA 3 4 Markov 2009 10 2 2 / 25 (GA) (GA) L ( 1) I := {0, 1} L f : I (0, ) M( 2) S := I M GA (GA) f (i) i I Markov 2009 10 2 3 / 25 (GA) ρ(i, j), i, j I

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N

KEIRIN

KEIRIN KEIRIN PCOSS CIO PC PC OSS OSS 2003 CIO 2003 IT IT 2006 2006 IT IT IT IT 2008 2008 IT IT 2001 2001 5IT IT 5IT IT IT IT (NGN) Web2.0 (NGN) Web2.0 2005 IT CIO 2005 2005 IT CIO 2006 CIOIT IT SE 2006

日本内科学会雑誌第96巻第7号

DVIOUT-HYOU

() P. () AB () AB ³ ³, BA, BA ³ ³ P. A B B A IA (B B)A B (BA) B A ³, A ³ ³ B ³ ³ x z ³ A AA w ³ AA ³ x z ³ x + z +w ³ w x + z +w ½ x + ½ z +w x + z +w x,,z,w ³ A ³ AA I x,, z, w ³ A ³ ³ + + A ³ A A P.

2 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a 2 + b 2 α (norm) N(α) = a 2 + b 2 = αα = α 2 α (spure) (trace) 1 1. a R aα =

1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a + b α (norm) N(α) = a + b = αα = α α (spure) (trace) 1 1. a R aα = aα. α = α 3. α + β = α + β 4. αβ = αβ 5. β 0 6. α = α ( ) α = α

XV-Z10000(J)Ł\1-4.p65

http://www.sharp.co.jp/ 4 2-JW age 2 2..5, :42 2 age 2 2..5, :44 3 age 3 2..5, :44 4 2..5, :44 age 4 5 2..5, :44 age 5 6 2..5, :44 age 6 7 2..5, :44 age 7 8 age 8 2..5, :45 75 76 9 age 9 2..5, :45 4 4

x V x x V x, x V x = x + = x +(x+x )=(x +x)+x = +x = x x = x x = x =x =(+)x =x +x = x +x x = x ( )x = x =x =(+( ))x =x +( )x = x +( )x ( )x = x x x R

V (I) () (4) (II) () (4) V K vector space V vector K scalor K C K R (I) x, y V x + y V () (x + y)+z = x +(y + z) (2) x + y = y + x (3) V x V x + = x (4) x V x + x = x V x x (II) x V, α K αx V () (α + β)x

α β *2 α α β β α = α 1 β = 1 β 2.2 α 0 β *3 2.3 * *2 *3 *4 (µ A ) (µ P ) (µ A > µ P ) 10 (µ A = µ P + 10) 15 (µ A = µ P +

Armitage 1 1.1 2 t *1 α β 1.2 µ x µ 2 2 2 α β 2.1 1 α β α ( ) β *1 t t 1 α β *2 α α β β α = α 1 β = 1 β 2.2 α 0 β 1 0 0 1 1 5 2.5 *3 2.3 *4 3 3.1 1 1 1 *2 *3 *4 (µ A ) (µ P ) (µ A > µ P ) 10 (µ A = µ P

MOS FET c /(17)

1 -- 7 1 2008 9 MOS FT 1-1 1-2 1-3 1-4 c 2011 1/(17) 1 -- 7 -- 1 1--1 2008 9 1 1 1 1(a) VVS: Voltage ontrolled Voltage Source v in µ µ µ 1 µ 1 vin 1 + - v in 2 2 1 1 (a) VVS( ) (b) S( ) i in i in 2 2 1

朕醩佑宖醸æ−žã†®ã†�ã‡†ã†®æ··å’‹æŁ´æŁ°è¨‹çfl»ã…¢ã…⁄ã…«

1 / 34 Li-Yao,, Li-Yao The Life-Cycle Effects of House Price Changes (Li-Yao ),,,, ( ) 1 ω ( ) ω 1 γ Ct Ht t T βt U(C t, H t, N t) = N t N t t T βt N t 1 γ H t : t C t : t β : ω : γ : W. Li, R. Yao, The

‚æ62›ñ”©fi®”Ô‰Z‘p›ï‘Ü

1. z dr er r sinθ dϕ eϕ r dθ eθ dr θ dr dθ r x 0 ϕ r sinθ dϕ r sinθ dϕ y dr dr er r dθ eθ r sinθ dϕ eϕ 2. (r, θ, φ) 2 dr 1 h r dr 1 e r h θ dθ 1 e θ h

IB IIA 1 1 r, θ, φ 1 (r, θ, φ)., r, θ, φ 0 r

r d 2r d l d (a) (b) (c) 1: I(x,t) I(x+ x,t) I(0,t) I(l,t) V in V(x,t) V(x+ x,t) V(0,t) l V(l,t) 2: 0 x x+ x 3: V in 3 V in x V (x, t) I(x, t

1 1 2 2 2r d 2r d l d (a) (b) (c) 1: I(x,t) I(x+ x,t) I(0,t) I(l,t) V in V(x,t) V(x+ x,t) V(0,t) l V(l,t) 2: 0 x x+ x 3: V in 3 V in x V (x, t) I(x, t) V (x, t) I(x, t) V in x t 3 4 1 L R 2 C G L 0 R 0

(Compton Scattering) Beaming 1 exp [i (k x ωt)] k λ k = 2π/λ ω = 2πν k = ω/c k x ωt ( ω ) k α c, k k x ωt η αβ k α x β diag( + ++) x β = (ct, x) O O x

Compton Scattering Beaming exp [i k x ωt] k λ k π/λ ω πν k ω/c k x ωt ω k α c, k k x ωt η αβ k α x β diag + ++ x β ct, x O O x O O v k α k α β, γ k γ k βk, k γ k + βk k γ k k, k γ k + βk 3 k k 4 k 3 k

第1章 微分方程式と近似解法

April 12, 2018 1 / 52 1.1 ( ) 2 / 52 1.2 1.1 1.1: 3 / 52 1.3 Poisson Poisson Poisson 1 d {2, 3} 4 / 52 1 1.3.1 1 u,b b(t,x) u(t,x) x=0 1.1: 1 a x=l 1.1 1 (0, t T ) (0, l) 1 a b : (0, t T ) (0, l) R, u

70 : 20 : A B (20 ) (30 ) 50 1

70 : 0 : A B (0 ) (30 ) 50 1 1 4 1.1................................................ 5 1. A............................................... 6 1.3 B............................................... 7 8.1 A...............................................

( )

) ( ( ) 3 15m t / 1.9 3 m t / 0.64 3 m ( ) ( ) 3 15m 3 1.9m / t 0.64m 3 / t ) ( β1 β 2 β 3 y ( ) = αx1 X 2 X 3 ( ) ) ( ( ) 3 15m t / 1.9 3 m 3 90m t / 0.64 3 m ( ) : r : ) 30 ( 10 0.0164

1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2

1.500 m X Y 0.200 m 0.200 m 0.200 m 0.200 m 0.200 m 0.000 m 1.200 m m 0.150 m 0.150 m m m 2 24.5 N/ 3 18.0 N/ 3 30.0 0.60 ( ) qa 50.79 N/ 2 0.0 N/ 2 20.000 20.000 15.000 15.000 X(m) Y(m) (kn/m 2 ) 10.000

授業研究第1日目

1 1 1 0. (sextant) ( ) 2 1. IB I AB I AI E H H E B GHE CIHE ( ) 2 2 I H A (0 ) ( ) 3 2 2 θ = α + γ β + γ = θ + α β + γ = ( α + γ ) + α β = 2 α + γ γ C H CIG ( ) 4 2. John Hadley 1731 5 ( (octant)) Captain

医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. このサンプルページの内容は, 第 2 版 1 刷発行時のものです.

医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. http://www.morikita.co.jp/books/mid/009192 このサンプルページの内容は, 第 2 版 1 刷発行時のものです. i 2 t 1. 2. 3 2 3. 6 4. 7 5. n 2 ν 6. 2 7. 2003 ii 2 2013 10 iii 1987

LLG-R8.Nisus.pdf

d M d t = γ M H + α M d M d t M γ [ 1/ ( Oe sec) ] α γ γ = gµ B h g g µ B h / π γ g = γ = 1.76 10 [ 7 1/ ( Oe sec) ] α α = λ γ λ λ λ α γ α α H α = γ H ω ω H α α H K K H K / M 1 1 > 0 α 1 M > 0 γ α γ =

untitled

PGF 17 6 1 11 1 12 1 2 21 2 22 2 23 3 1 3 1 3 2 3 3 3 4 3 5 4 6 4 2 4 1 4 2 4 3 4 4 4 5 5 3 5 1 5 2 5 5 5 5 4 5 1 5 2 5 3 6 5 6 1 6 2 6 6 6 24 7 1 7 1 7 2 7 3 7 4 8 2 8 1 8 2 8 3 9 4 9 5 9 6 9 3 9 1 9

untitled

The 23rd Annual Meeting of the Japanese Association of Cardiac Rehabilitation! The 23rd Annual Meeting of the Japanese Association of Cardiac Rehabilitation The 23rd Annual Meeting of the Japanese Association

1 (Berry,1975) 2-6 p (S πr 2 )p πr 2 p 2πRγ p p = 2γ R (2.5).1-1 : : : : ( ).2 α, β α, β () X S = X X α X β (.1) 1 2

2005 9/8-11 2 2.2 ( 2-5) γ ( ) γ cos θ 2πr πρhr 2 g h = 2γ cos θ ρgr (2.1) γ = ρgrh (2.2) 2 cos θ θ cos θ = 1 (2.2) γ = 1 ρgrh (2.) 2 2. p p ρgh p ( ) p p = p ρgh (2.) h p p = 2γ r 1 1 (Berry,1975) 2-6

untitled

(a) (a) 1010 LC/MS JIS K 04501010 JIS K 04502010 JIS K 04503010 JIS K 04504010 (2) ( JIS K 04505010 JIS K 04506010 JIS K 0128 No 1 PCBPCB 2 αhchβhchγhchδhchp,p DDTp,p DDEp,p DDD I IItranscis transcis HCB

ACQUITY UPC 2 ACQUITY UPC 2 A A+D3 D ml E 10 ml K μm K μm PDA ACQUITY UPC 2 BEH mm, 1.7 μm ACQUITY UPC 2 HSS C 18 SB 3.

UPC 2 Andrew Aubin Waters Corporation, Milford, MA, USA Waters ACQUITY UPC 2TM 6 tert- UltraPerformance Convergence Chromatography TM UPC 2 ACQUITY UPC 2 1 A A D3 E D3 K1 K2 UPC 2 A E K1 ACQUITY UPC 2

学会誌カラー（目次）／目次１３‐１月